Phio Pharmaceuticals (PHIO) Return on Sales (2016 - 2019)
Historic Return on Sales for Phio Pharmaceuticals (PHIO) over the last 8 years, with Q4 2019 value amounting to 427.95%.
- Phio Pharmaceuticals' Return on Sales fell 3746200.0% to 427.95% in Q4 2019 from the same period last year, while for Dec 2019 it was 427.95%, marking a year-over-year decrease of 3746200.0%. This contributed to the annual value of 424.19% for FY2019, which is 3708600.0% down from last year.
- Latest data reveals that Phio Pharmaceuticals reported Return on Sales of 427.95% as of Q4 2019, which was down 3746200.0% from 383.1% recorded in Q3 2019.
- Over the past 5 years, Phio Pharmaceuticals' Return on Sales peaked at 26.19% during Q3 2018, and registered a low of 1358.11% during Q1 2017.
- In the last 5 years, Phio Pharmaceuticals' Return on Sales had a median value of 178.36% in 2015 and averaged 271.32%.
- Per our database at Business Quant, Phio Pharmaceuticals' Return on Sales plummeted by -11350100bps in 2017 and then surged by 12607600bps in 2018.
- Over the past 5 years, Phio Pharmaceuticals' Return on Sales (Quarter) stood at 300.62% in 2015, then crashed by -57bps to 473.37% in 2016, then skyrocketed by 72bps to 133.47% in 2017, then skyrocketed by 60bps to 53.33% in 2018, then crashed by -702bps to 427.95% in 2019.
- Its Return on Sales stands at 427.95% for Q4 2019, versus 383.1% for Q3 2019 and 95.19% for Q2 2019.